Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D Richert

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurology|May 16, 2002
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"Nancy D Richert
Neurology|November 19, 2011
Does one guideline fit all?Nancy D Richert, Richard J Kryscio
Archives of Neurology|February 11, 2009
Visualizing the cause of gray matter atrophy in multiple sclerosisNancy D Richert, Eduard Kraft, Olaf Stüve
Annals of Neurology|January 3, 2013
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathyTarek A Yousry, Daniel Pelletier, Diego Cadavid, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Brain : a Journal of Neurology|June 25, 2003
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 yearsFrancesca Bagnato, Neal Jeffries, Nancy D Richert, et al.
Archives of Neurology|September 15, 2005
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluationsFrancesca Bagnato, Shiva Gupta, Nancy D Richert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2013
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathyMike P Wattjes, Nancy D Richert, Joep Killestein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2013
Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patientVasiliki N Ikonomidou, Nancy D Richert, Alexander Vortmeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2015
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MSMike P Wattjes, Martijn T Wijburg, Anke Vennegoor, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurology|May 16, 2002
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"Nancy D Richert
Neurology|November 19, 2011
Does one guideline fit all?Nancy D Richert, Richard J Kryscio
Archives of Neurology|February 11, 2009
Visualizing the cause of gray matter atrophy in multiple sclerosisNancy D Richert, Eduard Kraft, Olaf Stüve
Annals of Neurology|January 3, 2013
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathyTarek A Yousry, Daniel Pelletier, Diego Cadavid, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Brain : a Journal of Neurology|June 25, 2003
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 yearsFrancesca Bagnato, Neal Jeffries, Nancy D Richert, et al.
Archives of Neurology|September 15, 2005
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluationsFrancesca Bagnato, Shiva Gupta, Nancy D Richert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 7, 2013
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathyMike P Wattjes, Nancy D Richert, Joep Killestein, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2013
Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patientVasiliki N Ikonomidou, Nancy D Richert, Alexander Vortmeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 16, 2015
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MSMike P Wattjes, Martijn T Wijburg, Anke Vennegoor, et al.
Pageof 2